Company Search:
Advanced Search
Sponsored Links
Eurofins-Cerep SA Company Snapshot
Eurofins-Cerep SA operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eurofins-Cerep SA with three other companies in this sector in France: Adocia SAS (2016 sales of 22.49 million Euro [US$27.83 million] of which 100% was Regenerative Medicine), Oncodesign Sa (11.27 million Euro [US$13.95 million] ), and Inventiva SA (9.45 million Euro [US$11.69 million] ).

Sales Analysis. During the year ended December of 2016, sales at Eurofins-Cerep SA were 23.44 million Euro (US$29.01 million). This is an increase of 4.1% versus 2015, when the company's sales were 22.51 million Euro. The sales level in 2016 was fairly close to the level five years ago: in 2011, Eurofins-Cerep SA had sales of 22.82 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Eurofins-Cerep SA
  Stock Performance Chart for Eurofins-Cerep SA
  Stock Data: Recent Stock Performance:
  Current Price (4/9/2018): 5,400.00
(Figures in Euro)
1 Week n/a   13 Weeks 3.8%  
4 Weeks n/a   52 Weeks 8.0%  
Eurofins-Cerep SA Key Data:
  Ticker: ALECR Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 23,437,623
(Year Ending Jan 2017).
Employees: 178
  Currency: Euro Market Cap: 27,237,600
  Fiscal Yr Ends: December Shares Outstanding: 5,044
  Share Type: Actions Ordinaires Closely Held Shares: 4,831
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.